Ab­b­Vie, Enan­ta hep C com­bo looks stel­lar in CKD study as ri­vals hus­tle along the lat­est cures

There are a va­ri­ety of com­bo ther­a­pies on the mar­ket now that can ef­fec­tive­ly cure the large ma­jor­i­ty of he­pati­tis C cas­es. But over the last few days we’ve been treat­ed to a slate of new tri­als un­der­scor­ing the ef­fi­ca­cy of new com­bos that can root out out the virus in key pock­ets of pa­tients, with in­ves­ti­ga­tors pre­sent­ing new da­ta at the An­nu­al Meet­ing of the Amer­i­can As­so­ci­a­tion for the Study of Liv­er Dis­eases in Boston.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER